Dr Remi Terranova - Novartis

Masterclass title:  To be confirmed

Dr Scott Henry - Senior Vice President of Preclinical Development, Ionis Pharmaceuticals

Masterclass title:  Understanding the Mechanism for Dose - Dependent Thrombocytopenia Associated with 2’MOE Antisense Oligonucleotides

Dr Ewan St. John Smith - Reader in Nociception, Deputy Head of Department, Department of Pharmacology, University of Cambridge

Seminar title:  Bedside to bench and back again, a path to translational pain research?

Dr Walid Khaled - Group Leader, Department of Pharmacology, University of Cambridge

Seminar title:  Is cancer prevention possible? - Lessons from model organisms

Dr Francis O'Reilly - Postdoctoral fellow, Technical University of Berlin

Seminar title:  Discovering the topology of protein complexes in situ using structural proteomics

Dr Julia Fentem - Head of SEAC & Colworth Site Leader, Unilever

Seminar title:  How research & innovation in toxicology has transformed our approach to assessing the safety of consumer products - some successes & future challenges

The Unit is organizing a half-day symposium to address emerging challenges and future perspectives regarding the safety of RNA therapeutics.

Registration is required but is free.

Please email registration@mrc-tox.cam.ac.uk

Dr Catherine Wilison - Group Leader, Department of Pharmacology, University of Cambridge

Seminar title:  Developing a transient, cell-free mRNA cardiac regenerative therapeutic 

Dr Luke Berchowitz - Assistant Professor of Genetics & Development, Columbia University

Seminar title:  The secret lives of meiotic RNA binding proteins

Dr Andreas Bender - Reader for Molecular Informatics, Department of Chemistry, University of Cambridge

Associate Director Computational ADME and Safety (Clinical Pharmacology & Safety Sciences/Data Science and Artificial Intelligence - CPSS/DSAI) at AstraZeneca Cambridge